Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Unknown 9Not yet recruiting 3Recruiting 2Completed 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 22Gastrointestinal 8Head & Neck 5Sarcoma 3Gynecologic 3Breast 3Tumor-Agnostic 2Genitourinary 2Endocrine 1Dermatologic 1CNS 1

Conditions

Platinum-resistant Ovarian Cancer (PROC) 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 12pembrolizumab 7fluzoparib 7Drug Therapy 7Radiotherapy 6camrelizumab 5apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × anlotinib × Gynecologic × Clear all
NCT07489300 2026-03-24

BACON

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07075250 2025-07-20

RIFOC003

Peking University People's Hospital

Phase 4 Not yet recruiting
30 enrolled
Gynecologic

Platinum-resistant Ovarian Cancer (PROC)

NCT05550558 2022-09-28

CAN-RESPOND

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
43 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡